Clinical trial
Intraclass Safety and Efficacy Comparison Among SGLT-2 Inhibitors in Elderly Patients With Type 2 Diabetes. A Pragmatic, Phase IV, Multicenter, Open-label, Randomised Controlled Trial.
NCT04796428 is registered in ClinicalTrials.gov with Center for Outcomes Research and Clinical Epidemiology, Italy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intraclass Safety and Efficacy Comparison Among SGLT-2 Inhibitors in Elderly Patients With Type 2 Diabetes. A Pragmatic, Phase IV, Multicenter, Open-label, Randomised Controlled Trial.
- Lead sponsor
- Center for Outcomes Research and Clinical Epidemiology, Italy
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2021
- Completion date
- December 31, 2023
- Enrollment
- 1,167 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.